MPD: Phenotype measures mapped to MP:0009745, abnormal behavioral response to xenobiotic

Phenotype measures directly associated with ontology term
MP:0009745 'abnormal behavioral response to xenobiotic'

This list only includes measures mapped to MP:0009745 directly. Measures mapped to its ontology descendants are not included. Alternatively, you can show measures mapped to MP:0009745 AND its descendants.

MP:0000950 abnormal seizure response to pharmacological agent
MP:0001425 abnormal alcohol consumption
MP:0001988 cocaine preference
MP:0002553 preference for addictive substance
MP:0009774 abnormal behavioral withdrawal response
MP:0012733 abnormal behavioral response to methamphetamine
MP:0020157 abnormal behavioral response to alcohol
MP:0020158 abnormal behavioral response to cocaine
MP:0020159 abnormal behavioral response to morphine
MP:0020160 abnormal behavioral response to nicotine
MP:0020895 abnormal acute locomotor response to cocaine
MP:0020896 abnormal locomotor sensitization to cocaine
MP:0020897 abnormal initiation of locomotor sensitization to cocaine
MP:0020898 abnormal expression of locomotor sensitization to cocaine
MP:0020899 abnormal cocaine conditioned locomotor activation

This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Crabbe2:4	Crabbe2	monitoring system	diazepam	horizontal distance traveled, immediately to 15 min post-injection [cm] horiz_DZ 15504 baseline doses mg/kg: 2 4 8 16	inbred	15	m	6-7wks	N=8	1998

Crabbe2:9	Crabbe2	monitoring system	diazepam	vertical (rearing) activity, immediately to 15 min post-injection [n] vertical_DZ 15509 baseline doses mg/kg: 2 4 8 16	inbred	15	m	6-7wks	N=8	1998

Crabbe2:19	Crabbe2	rotarod	diazepam	latency to fall from 5 rpm rotarod, 0 min post-injection [s] fall_DZ20 15519 trial block1 trial block2	inbred	15	m	6-7wks	N=13	1998

Crowley1:7	Crowley1	inclined screen test	haloperidol	latency to move four paws, extrapyramidal side effects [s] latency 39407 day: 0 3 7 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:12	Crowley1	open field test	haloperidol	distance traveled, 60 min test [cm] horizontal_act 39412 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:17	Crowley1	open field test	haloperidol	vertical activity, beam breaks, 60 min test [n] vertical_act 39417 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:21	Crowley1	open field test	haloperidol	repetitive behavior, breaking of same beam, 60 min test [n] stereotypy 39421 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:25	Crowley1	open field test	haloperidol	center occupancy, percentage of total time [%] pct_center 39425 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:29	Crowley1	behavior observation	haloperidol	tongue protrusions, 15 min test [n] tongue 39429 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:33	Crowley1	behavior observation	haloperidol	overt chewing movements, 15 min test [n] overtchew 39433 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:37	Crowley1	behavior observation	haloperidol	subtle chewing movements, 15 min test [n] subtlechew 39437 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:41	Crowley1	behavior observation	haloperidol	jaw tremor duration, 15 min test [s] jawtremor 39441 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Gershenfeld1:3	Gershenfeld1	tail suspension test	imipramine	TST duration of immobility, treatment group, 6 min test [s] TST_Rx 16203 baseline imipramine 30mg/kg	inbred	12	m	5-10wks	N=5	2003

Gershenfeld1:5	Gershenfeld1	tail suspension test	imipramine	TST immobility percentage, imipramine vs. saline, 6 min test [%] TST_immobility_pct 16205	inbred	12	m	5-10wks	N=5	2003

Gershenfeld1:10	Gershenfeld1	light-dark box	imipramine	number of transitions between light and dark compartments in 10 min [n] LDtransits 16210 baseline imipramine 30mg/kg	inbred	12	m	5-10wks	N=5	2003

Gershenfeld1:12	Gershenfeld1	open field test	imipramine	distance traveled in 5 min [cm] OFTactivity 16212 baseline imipramine 30mg/kg	inbred	12	m	5-10wks	N=5	2003

Gershenfeld1:14	Gershenfeld1	open field test	imipramine	vertical movements, rearing, 15 min test [n] OFTrearing 16214 baseline imipramine 30mg/kg	inbred	12	m	5-10wks	N=5	2003

Gershenfeld1:16	Gershenfeld1	open field test	imipramine	average center time, 2 trials [s] OFTcenter 16216 baseline imipramine 30mg/kg	inbred	12	m	5-10wks	N=5	2003

Gershenfeld1:18	Gershenfeld1	open field test	imipramine	number of fecal boli, 15 min test [n] defecation 16218 baseline imipramine 30mg/kg	inbred	12	m	5-10wks	N=5	2003

Gould1:1	Gould1	forced swim test	lithium	duration of immobility [s] immob 37401 lithium dose [mg/kg]: 0(saline) 200 300 400	inbred	11	m	7-8wks	N=8	2011

Filter Table Results